Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0000310158-25-000063
Filing Date
2025-11-12
Accepted
2025-11-12 16:11:52
Documents
2
Period of Report
2025-09-30
Effectiveness Date
2025-11-12

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2253
2 form13fhrinfotable93025.html INFORMATION TABLE  
2 form13fhrinfotable93025.xml INFORMATION TABLE 7305
  Complete submission text file 0000310158-25-000063.txt   11076
Mailing Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065
Business Address 126 EAST LINCOLN AVENUE P.O. BOX 2000 RAHWAY NJ 07065 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 13F-HR | Act: 34 | File No.: 028-25193 | Film No.: 251472831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)